1887

Abstract

SUMMARY

We constructed a non-defective bovine adenovirus type 3 recombinant (BAd3-Luc) containing the firefly luciferase gene inserted in the early region 3 (E3) of the BAd3 genome. Deletion of a 696 bp I–I E3 segment and insertion of the luciferase gene in E3 was confirmed by Southern blot analyses. Luciferase was expressed in Madin-Darby bovine kidney cells infected with BAd3-Luc as measured by enzymic assays and Western blotting. Analyses of luciferase expression in the presence or absence of 1---arabinofuranosyl-cytosine indicated that approximately 70–75% of luciferase expression was dependent on viral DNA replication, suggesting that transcription of the gene was at least partially under the control of a late promoter. Although yields of infectious virus for BAd3-Luc were approximately 10-fold lower than for wild-type virus, replication of the vector was still relatively efficient. In a Western blot experiment, anti-luciferase antibody reacted with a 62 kDa protein which is of the same molecular mass as the purified firefly luciferase polypeptide. Luciferase was also expressed in the 293 cell line infected with BAd3-Luc for at least 6 days postinfection as monitored by luciferase assays. Based on these observations we suggest that BAd-based expression vectors should have excellent potential for the development of recombinant vaccines for cattle and may also be suitable as vectors for gene transfer into human cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-1-93
1995-01-01
2021-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/1/JV0760010093.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-1-93&mimeType=html&fmt=ahah

References

  1. Andersson M., Paabo S., Nilsson T., Peterson P. A. 1985; Impaired intracellular transport of class I MHC antigens as a possible means for adenovirus to evade immune surveillance. Cell 43:215–222
    [Google Scholar]
  2. Berkner K. L. 1988; Development of adenovirus vectors for expression of heterologous genes. BioTechniques 6:616–629
    [Google Scholar]
  3. Berkner K. L., Sharp P. A. 1984; Expression of dihydrofolate reductase and of the adjacent Elb region in an Ad5-dihydrofolate reductase recombinant virus. Nucleic Acids Research 12:1925–1941
    [Google Scholar]
  4. Bett A. J., Prevec L., Graham F. L. 1993; Packaging capacity and stability of human adenovirus type 5 vectors. Journal of Virology 67:5911–5921
    [Google Scholar]
  5. Birnboim H. C., Doly J. 1978; A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research 7:1513–1523
    [Google Scholar]
  6. Burgert H. -G., Kvist S. 1985; An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987–997
    [Google Scholar]
  7. Burgert H.-G., Kvist S. 1987; The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO Journal 6:2019–2026
    [Google Scholar]
  8. Cai F., Bourbonniere M., Tang D., Hu S. -L., Weber J. M. 1990; Nucleotide and deduced amino acid sequence of the bovine adenovirus type 3 proteinase. Nucleic Acids Research 18:5568
    [Google Scholar]
  9. Carlin C. R., Tollefson A. E., Bradley H. A., Hoffman B. L., Wold W. S. M. 1989; Epidermal growth factor is downregulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell 57:135–144
    [Google Scholar]
  10. Chanda P. K., Natuk R. J., Mason B. B., Bhat B. M., Greenberg L., Dheer S. K., Molnar-Kimber K. L., Mizutani S., Lubeck M. D., Davis A. R., Hung P. P. 1990; High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175:535–547
    [Google Scholar]
  11. Cladaras C., Wold W. S. M. 1985; The sequence of the early E3 transcription unit of adenovirus 5. Virology 140:28–13
    [Google Scholar]
  12. Darbyshire J. H. 1968; Bovine adenoviruses. Journal of American Veterinary Medical Association 152:786–794
    [Google Scholar]
  13. Dewar R. L., Natarajan V., Vasudbvachari M. B., Salzman N. P. 1989; Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. Journal of Virology 63:129–136
    [Google Scholar]
  14. De Wet J. R., Wood K. V., Deluca M., Helinski D. R., Subramani S. 1987; Firefly luciferase gene: structure and ex- pression in mammalian cells. Molecular and Cellular Biology 7:725–737
    [Google Scholar]
  15. Dower W. J., Miller J. F., Ragsdale C. W. 1988; High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Research 16:6127–6145
    [Google Scholar]
  16. Elgadi M. M., Haj-Ahmad Y. 1992; Molecular cloning and restriction enzyme analysis of bovine adenovirus type 3. Intervirologv 34:124–132
    [Google Scholar]
  17. Elgadi M., Rghei N., Haj-Ahmad Y. 1993; Sequence and sequence analysis of El and pIX regions of the BAV3 genome. Intervirology 36:113–120
    [Google Scholar]
  18. Ghosh-Choudhury G., Haj-Ahmad Y., Graham F. L. 1987; Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO Journal 6:1733–1739
    [Google Scholar]
  19. Ginsberg H. S., Lundholm-Beauchamp U., Horswood R. L., Pernis B., Wold W. S. M., Chanock R. M., Prince G. A. 1989; Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proceedings of the National Academy of SciencesUSA 86:3823–3827
    [Google Scholar]
  20. Gooding L. R., Elmore L. W., Tollefson A. E., Brody H. A., Wold W. S. M. 1988; A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341–346
    [Google Scholar]
  21. Graham F. L. 1990; Adenoviruses as expression vectors and recombinant vaccines. Trends in Biotechnology 8:85–87
    [Google Scholar]
  22. Graham F. L., Prevec L. 1991; Manipulation of adenovirus vectors. In Methods in Molecular Biology 7 Gene Transfer and Expression Protocols 109–128 Murray E. J. Clifton, New Jersey: The Humana Press;
    [Google Scholar]
  23. Graham F. L., Prevec L. 1992; Adenovirus expression vectors and recombinant vaccines. In Vaccines; New Approaches to Immuno- logical Problems363–390 Ellis R. W. Boston: Butterworth-Heinemann;
    [Google Scholar]
  24. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
  25. Haj-Ahmad Y., Graham F. L. 1986; Development of a helper independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. Journal of Virology 57:267–274
    [Google Scholar]
  26. Héerissé J., Galibert F. 1981; Nucleotide sequence of the EcoRI- E fragment of adenovirus 2 genome. Nucleic Acids Research 9:1229–1249
    [Google Scholar]
  27. Hérissé J., Courtois G., Galibert F. 1980; Nucleotide sequence of the EcoRI-D fragment of adenovirus 2 genome. Nucleic Acids Research 8:2173–2192
    [Google Scholar]
  28. Horton T. M., Tollefson A. E., Wold W. S. M., Gooding L. R. 1990; A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes. Journal of Virology 64:1250–1255
    [Google Scholar]
  29. Hu S. -L., Hays W. W., Potts D. E. 1984; Sequence homology between bovine and human adenoviruses. Journal of Virology 49:604–608
    [Google Scholar]
  30. Johnson D. C., Ghosh-Choudhury G., Smiley J. R., Fallis L., Graham F. L. 1988; Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164:1–14
    [Google Scholar]
  31. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
    [Google Scholar]
  32. Lubeck M. D., Davis A. R., Chengalvala M., Natuk R. J., Morin J. E., Molnar-Kimber K., Mason B. B., Bhat B. M., Mizutani S., Hung P. P., Purcell R. H. 1989; Immuno- genicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proceedings of the National Academy of Sciences USA 86:6763–6767
    [Google Scholar]
  33. Mattson D. E. 1973; Naturally occurring infection of calves with a bovine adenovirus. American Journal of Veterinary Research 34:623–629
    [Google Scholar]
  34. Mittal S. K., Prevec L., Babiuk L. A., Graham F. L. 1992; Sequence analysis of bovine adenovirus type 3 early region 3 and fibre protein genes. Journal of General Virology 73:3295–3000
    [Google Scholar]
  35. Mittal S. K., Prevec L., Babiuk L. A., Graham F. L. 1993; Corrigendum. Sequence analysis of bovine adenovirus type 3 early region 3 and fibre protein genes. Journal of General Virology 74:2825
    [Google Scholar]
  36. Mittal S. K., McDermott M. R., Johnson D. C., Prevec L., Graham F. L. 1993b; Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research 28:67–90
    [Google Scholar]
  37. Prevec L., Campbell J. B., Christie B. S., Belbeck L., Graham F. L. 1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
    [Google Scholar]
  38. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J. -C., Perricaudet M., Kahn A. 1993; Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647–650
    [Google Scholar]
  39. Rosenheld M. A., Siegfied W., Yoshimura K., Yoneyama K., Fukayama M., Stier L. E., Paakko P. K., Gilardi P., Strattord-Perricaudet L. D., Perricaudet M., Jallat S., Pavirani A., Lecocq J.-P., Crystal R. G. 1991; Adenovirus-mediated transfer of a recombinantα1-antitrypsin gene to the lung epithelium in vivo. Science 252:431–134
    [Google Scholar]
  40. Rosenheld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L., Perricaudet M., Guggino W. B., Pavirani A., Lecocq J. -P., Crystal R. G. 1992; In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:141–155
    [Google Scholar]
  41. Ruben M., Bacchetti S., Graham F. L. 1983; Covalently closed circles of adenovirus 5 DNA. Nature 301:172–174
    [Google Scholar]
  42. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2. New York: Cold Spring Harbour Laboratory;
    [Google Scholar]
  43. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
  44. Stott E. J., Thomas L. H., Collins A. P., Crouch S., Jebbett J., Smith G. S., Luther P. D., Caswell R. 1980; A survey of virus infections of the respiratory tract of cattle and their association with disease. Journal of Hygiene 85:257–270
    [Google Scholar]
  45. Stratford-Perricaudet L. D., Levrero M., Chasse J. -F., Perricaudet M., Briand P. 1990; Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Human Gene Therapy 1:241–256
    [Google Scholar]
  46. Tollefson A. E., Stewart A. R., Yei S., Saha S. K., Wold W. S. M. 1991; The 10,400- and 14,500-Dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. Journal of Virology 65:3095–3105
    [Google Scholar]
  47. Wold W. S. M., Gooding L. R. 1991; Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1–8
    [Google Scholar]
  48. Yanisch-Perron C., Vieira J., Messing J. 1985; Improved MI3 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103–119
    [Google Scholar]
  49. Zheng B., Mittal S. K., Graham F. L., Prevec L. 1994; The El sequence of bovine adenovirus type 3 and complementation of human adenovirus type 5 El A function in bovine cells. Virus Research 31:163–186
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-1-93
Loading
/content/journal/jgv/10.1099/0022-1317-76-1-93
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error